Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Laboratory aspects of intermittent drug therapy.

× No keyword cloud information.

11 in total

1. FURTHER STUDIES ON THE TIME/CONCENTRATION RELATIONSHIPS OF ISONIAZID AND TUBERCLE BACILLI IN VITRO.

Authors: A R ARMSTRONG
Journal: Am Rev Respir Dis Date: 1965-03

2. Time-concentration relationships of isoniazid with tubercle bacilli in vitro.

Authors: A R ARMSTRONG
Journal: Am Rev Respir Dis Date: 1960-04

3. Action of rifamycins on RNA polymerase.

Authors: W Wehrli; J Nüesch; F Knüsel; M Staehelin
Journal: Biochim Biophys Acta Date: 1968-03-18

4. Inhibition of DNA-dependent RNA synthesis by rifamycins.

Authors: H Umezawa; S Mizuno; H Yamazaki; K Nitta
Journal: J Antibiot (Tokyo) Date: 1968-03 Impact factor: 2.649

5. The specific inhibition of the DNA-directed RNA synthesis by rifamycin.

Authors: G Hartmann; K O Honikel; F Knüsel; J Nüesch
Journal: Biochim Biophys Acta Date: 1967

6. Mode of action of rafamycin on the RNA polymerase reaction.

Authors: A Sippel; G Hartmann
Journal: Biochim Biophys Acta Date: 1968-03-18

7. Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis.

Authors: J M Dickinson; G A Ellard; D A Mitchison
Journal: Tubercle Date: 1968-12

8. Madras study of two once-weekly regimens: laboratory aspects.

Authors: S P Tripathy
Journal: Bull Int Union Tuberc Date: 1970-06

9. Suitability of rifampicin for intermittent administration in the treatment of tuberculosis.

Authors: J M Dickinson; D A Mitchison
Journal: Tubercle Date: 1970-03

10. Isoniazid uptake and growth inhibition of Mycobacterium tuberculosis in relation to time and concentration of pulsed drug exposures.

Authors: W H Beggs; J W Jenne
Journal: Tubercle Date: 1969-12

14 in total

1. What is the best dosage schedule for patients?

Authors: W Fox
Journal: J R Soc Med Date: 1992-05 Impact factor: 5.344

Review 2. An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.

Authors: Jotam Pasipanodya; Tawanda Gumbo
Journal: Antimicrob Agents Chemother Date: 2010-10-11 Impact factor: 5.191

3. Tuberculosis 2004: challenges and opportunities.

Authors: Jeffrey Glassroth
Journal: Trans Am Clin Climatol Assoc Date: 2005

Review 4. Philip Ellman lecture. The modern management and therapy of pulmonary tuberculosis.

Authors: W Fox
Journal: Proc R Soc Med Date: 1977-01

5. Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs.

Authors: Lucila Garcia-Contreras; Danielle J Padilla-Carlin; Jean Sung; Jarod VerBerkmoes; Pavan Muttil; Katharina Elbert; Charles Peloquin; David Edwards; Anthony Hickey
Journal: J Pharm Sci Date: 2016-11-11 Impact factor: 3.534

6. Compliance of patients and physicians: experience and lessons from tuberculosis-II.

Authors: W Fox
Journal: Br Med J (Clin Res Ed) Date: 1983-07-09

7. Comparison of CO2 generation (BACTEC) and viable-count methods to determine the postantibiotic effect of antimycobacterial agents against Mycobacterium avium complex.

Authors: G G Zhanel; M H Saunders; J N Wolfe; D J Hoban; J A Karlowsky; A M Kabani
Journal: Antimicrob Agents Chemother Date: 1998-01 Impact factor: 5.191

Laboratory aspects of intermittent drug therapy.